Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GLYC GlycoMimetics Inc

0,242

0,0255 (11,78%)

24 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more GlycoMimetics Charts.

GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more GlycoMimetics Charts.

News GlycoMimetics Inc

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 27 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
Dienstag 12 November 2024 (1 Monat vor) • PR Newswire (US)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Mittwoch 6 November 2024 (2 Monate vor) • Business Wire

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Montag 4 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 4 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement
Dienstag 29 Oktober 2024 (2 Monate vor) • AllPennyStocks.com

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 29 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 29 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
Dienstag 29 Oktober 2024 (2 Monate vor) • Business Wire

Weitere GlycoMimetics Inc News-Artikel

iShares MSCI EAFE Growth...

Deutsche Bank Luxembourg

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen